Remap Consulting GmbH
Remap Consulting provides an integrated approach to pharmaceutical pricing & market access solutions.
We are a specialist pricing, reimbursement and market access consultancy offering an integrated, evidence-based approach to optimising market access. Our strength lies in our ability to understand the market access challenges from your perspective and to develop payer-focused solutions tailored to your business needs.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Seven strategic steps to enhance patient recruitment & retention in your influenza studies
White Papers and Resources | November 29, 2024 | Innovative Trials
The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...
Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group
White Papers and Resources | November 26, 2024 | Genesis Research Group
A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...
Education, AI and More at ASH 2024
Press Releases | November 25, 2024 | Medscape Education
Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year's programs,...
Innovative Trials celebrates success for its groundbreaking Retention Patch Program
Press Releases | November 22, 2024 | Innovative Trials
Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)
Genesis Research Group unveils enhanced US market access data analytics
Press Releases | November 21, 2024 | Genesis Research Group
Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...
Stacking the odds in your favour with landscape analysis
White Papers and Resources | November 21, 2024 | Amiculum
By James Aird and Jess Choi
Health Awareness V Health Anxiety: Is the increase of online health content a help or hindrance?
White Papers and Resources | November 19, 2024 | Mednet
Medical Writer, Steph Gathercole, looks at the impact increased access to online health information has on the public through the lens of Anxiety
Insights and reflections from the Mtech Access transforming healthcare symposium
Press Releases | November 19, 2024 | Petauri Evidence
Our transforming healthcare symposium was held on Tuesday 5th November 2024. In this article, Prof Phil Richardson (Chief Innovation Officer, Mtech Access) shares his reflections from the day.
EU Joint Clinical Assessment (JCA) – Implications for Pharma and Medtech
White Papers and Resources | November 19, 2024 | Petauri Evidence
Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it...
Movember 2024 – Men’s Health
White Papers and Resources | November 18, 2024 | Innovative Trials
This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and mental health.